These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27077909)
1. In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control. Felker A; Nieuwenhuize S; Dolbois A; Blazkova K; Hess C; Low LW; Burger S; Samson N; Carney TJ; Bartunek P; Nevado C; Mosimann C PLoS One; 2016; 11(4):e0152989. PubMed ID: 27077909 [TBL] [Abstract][Full Text] [Related]
2. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Indra AK; Warot X; Brocard J; Bornert JM; Xiao JH; Chambon P; Metzger D Nucleic Acids Res; 1999 Nov; 27(22):4324-7. PubMed ID: 10536138 [TBL] [Abstract][Full Text] [Related]
3. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2. Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885 [TBL] [Abstract][Full Text] [Related]
5. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse. Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729 [TBL] [Abstract][Full Text] [Related]
6. Inducible gene inactivation in neurons of the adult mouse forebrain. Erdmann G; Schütz G; Berger S BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525 [TBL] [Abstract][Full Text] [Related]
7. Agonistic and synergistic activity of tamoxifen in a yeast model system. Graumann K; Jungbauer A Biochem Pharmacol; 2000 Jan; 59(2):177-85. PubMed ID: 10810452 [TBL] [Abstract][Full Text] [Related]
8. Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER. Jiang SY; Langan-Fahey SM; Stella AL; McCague R; Jordan VC Mol Endocrinol; 1992 Dec; 6(12):2167-74. PubMed ID: 1491696 [TBL] [Abstract][Full Text] [Related]
9. Contemporary zebrafish transgenesis with Tol2 and application for Cre/lox recombination experiments. Felker A; Mosimann C Methods Cell Biol; 2016; 135():219-44. PubMed ID: 27443928 [TBL] [Abstract][Full Text] [Related]
10. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Brocard J; Warot X; Wendling O; Messaddeq N; Vonesch JL; Chambon P; Metzger D Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14559-63. PubMed ID: 9405652 [TBL] [Abstract][Full Text] [Related]
13. Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation. Hirrlinger J; Requardt RP; Winkler U; Wilhelm F; Schulze C; Hirrlinger PG PLoS One; 2009 Dec; 4(12):e8354. PubMed ID: 20016782 [TBL] [Abstract][Full Text] [Related]
14. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Hayashi S; McMahon AP Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939 [TBL] [Abstract][Full Text] [Related]
15. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2. Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139 [TBL] [Abstract][Full Text] [Related]
17. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351. MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635 [TBL] [Abstract][Full Text] [Related]
18. An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen. Demirpence E; Semlali A; Oliva J; Balaguer P; Badia E; Duchesne MJ; Nicolas JC; Pons M Cancer Res; 2002 Nov; 62(22):6519-28. PubMed ID: 12438246 [TBL] [Abstract][Full Text] [Related]